Clinical Trials Browser

Phase 2 × Recruiting × Thalidomide × Clear all

NCT01356290 2026-02-23

MEMMAT

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

NCT06530576 2025-11-18

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic